Cargando…
A clinical tool for predicting survival in ALS
BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a progressive and usually fatal neurodegenerative disease. Survival from diagnosis varies considerably. Several prognostic factors are known, including site of onset (bulbar or limb), age at symptom onset, delay from onset to diagnosis and the use o...
Autores principales: | Knibb, Jonathan A, Keren, Noa, Kulka, Anna, Leigh, P Nigel, Martin, Sarah, Shaw, Christopher E, Tsuda, Miho, Al-Chalabi, Ammar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5136716/ https://www.ncbi.nlm.nih.gov/pubmed/27378085 http://dx.doi.org/10.1136/jnnp-2015-312908 |
Ejemplares similares
-
Relative preservation of triceps over biceps strength in upper limb-onset ALS: the ‘split elbow’
por: Khalaf, Roaya, et al.
Publicado: (2019) -
Genetic screening in sporadic ALS and FTD
por: Turner, Martin R, et al.
Publicado: (2017) -
Younger age of onset in familial amyotrophic lateral sclerosis is a result of pathogenic gene variants, rather than ascertainment bias
por: Mehta, Puja R, et al.
Publicado: (2019) -
Retrotransposons in the development and progression of amyotrophic lateral sclerosis
por: Savage, Abigail L, et al.
Publicado: (2019) -
Hypermetabolism in ALS is associated with greater functional decline and shorter survival
por: Steyn, Frederik J, et al.
Publicado: (2018)